Ekso Bionics shares jump 10.18% premarket after securing exclusive U.S. distribution deal for MediTouch's BalanceTutor rehabilitation system.

Ekso Bionics surged 10.18% in premarket trading following the announcement of an exclusive U.S. distribution agreement with MediTouch for the BalanceTutor rehabilitation system. The deal grants Ekso Bionics rights to distribute a patented 4D perturbation treadmill system designed to improve patient balance through simulated real-world disturbances. The company emphasized strategic alignment with its existing enterprise health solutions, leveraging shared customer touchpoints to expand market reach. MediTouch highlighted the partnership as a milestone to broaden access to its technology. The partnership is positioned to enhance Ekso Bionics’ offerings in medical rehabilitation, reinforcing its growth narrative amid a $11.5 million market capitalization.